Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z2VP
|
|||
| Former ID |
DNC009830
|
|||
| Drug Name |
N-hydroxy-9-oxo-9-phenylnonanamide
|
|||
| Synonyms |
CHEMBL99810; N-hydroxy-9-oxo-9-phenylnonanamide; SCHEMBL1521077; BDBM50114824; 9-Oxo-9-phenyl-nonanoic acid hydroxyamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H21NO3
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C(=O)CCCCCCCC(=O)NO
|
|||
| InChI |
1S/C15H21NO3/c17-14(13-9-5-4-6-10-13)11-7-2-1-3-8-12-15(18)16-19/h4-6,9-10,19H,1-3,7-8,11-12H2,(H,16,18)
|
|||
| InChIKey |
ZCJNQRRQDXSGEO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Eur J Med Chem. 2009 Jul;44(7):2868-76. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.